Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
M Stoll, … , R Metzger, T Unger
M Stoll, … , R Metzger, T Unger
Published February 1, 1995
Citation Information: J Clin Invest. 1995;95(2):651-657. https://doi.org/10.1172/JCI117710.
View: Text | PDF
Research Article Article has an altmetric score of 3

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  • Text
  • PDF
Abstract

Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.

Authors

M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 5 2 4 4 2 5 3 5 3 12 4 9 15 16 25 16 18 16 16 29 28 30 39 54 50 69 61 54 45 11 651
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 1999 (69)

Title and authors Publication Year
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
M Akishita, M Ito, JY Lehtonen, L Daviet, VJ Dzau, M Horiuchi
Journal of Clinical Investigation 1999
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
Y Tsutsumi, H Matsubara, H Masaki, H Kurihara, S Murasawa, S Takai, M Miyazaki, Y Nozawa, R Ozono, K Nakagawa, T Miwa, N Kawada, Y Mori, Y Shibasaki, Y Tanaka, S Fujiyama, Y Koyama, A Fujiyama, H Takahashi, T Iwasaka
Journal of Clinical Investigation 1999
The Renin-Angiotensin System and Its Receptors
U Stroth, T Unger
Journal of Cardiovascular Pharmacology 1999
Mechanism of action of angiotensin-receptor blocking agents
HM Siragy, M Bedigian
Current Hypertension Reports 1999
Effects of a novel angiotensin AT1 receptor antagonist, HR720, on rats with myocardial infarction
QG Xia, O Chung, H Spitznagel, S Sandmann, S Illner, B Rossius, G Jähnichen, A Reinecke, P Gohlke, T Unger
European Journal of Pharmacology 1999
Björn Fokow Award Lecture The angiotensin type 2 receptor
T Unger
Journal of Hypertension 1999
Novel actions of angiotensin II via its renal type-2 (AT2) receptor
RM Carey, ZQ Wang, HM Siragy
Current Hypertension Reports 1999
Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis
EA Kalkman, P Haren, PR Saxena, RG Schoemaker
European Journal of Pharmacology 1999
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells
PD Paolisa, A Porcellini, B Gigante, R Giliberti, A Lombardi, C Savoia, S Rubattu, M Volpe
Journal of Hypertension 1999
No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats
MP Schuijt, R Vries, PR Saxena, AH Danser
Journal of Hypertension 1999
Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition
S Miura, SS Karnik
Journal of Hypertension 1999
Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
WH Birkenhäger, PW de Leeuw
Journal of Hypertension 1999
Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts
M Tamura, YJ Chen, EF Howard, M Tanner, EJ Landon, PR Myers
European Journal of Pharmacology 1999
Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth
M Horiuchi, JY Lehtonen, L Daviet
Trends in Endocrinology & Metabolism 1999
Selective Potentiation of Angiotensin-Induced Constriction of Skeletal Muscle Resistance Arteries by Chronic Elevations in Dietary Salt Intake
DS Weber, JC Frisbee, JH Lombard
Microvascular Research 1999
Angiotensin II and extracellular matrix homeostasis
KT Weber, SK Swamynathan, RV Guntaka, Y Sun
The International Journal of Biochemistry & Cell Biology 1999
The Localization and Expression of the Renin–angiotensin System in the Human Placenta Throughout Pregnancy
AC Cooper, G Robinson, GP Vinson, WT Cheung, FB Pipkin
Placenta 1999
Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 Receptor
M Akishita, H Yamada, VJ Dzau, M Horiuchi
Biochemical and Biophysical Research Communications 1999
Vascular Response to Angiotensin II Is Exaggerated through an Upregulation of AT1 Receptor in AT2 Knockout Mice
M Tanaka, S Tsuchida, T Imai, N Fujii, H Miyazaki, T Ichiki, M Naruse, T Inagami
Biochemical and Biophysical Research Communications 1999
Angiotensin II and nitric oxide: a question of balance
LJ Millatt, EM Abdel-Rahman, HM Siragy
Regulatory Peptides 1999
The AT2 receptor: fact, fancy and fantasy
M Gasparo, HM Siragy
Regulatory Peptides 1999
Angiotensin II and connective tissue: homeostasis and reciprocal regulation
KT Weber
Regulatory Peptides 1999
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells:
PD Paolisa, A Porcellini, B Gigante, R Giliberti, A Lombardi, C Savoia, S Rubattu, M Volpe
Journal of Hypertension 1999
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data
DP Brooks, EH Ohlstein, RR Ruffolo
American Heart Journal 1999
AT2 receptor stimulation induces generation of ceramides in PC12W cells
S Gallinat, S Busche, S Schütze, M Krönke, T Unger
FEBS Letters 1999
An A/T-rich cis-element is essential for rat angiotensin II type 1A receptor transcription in vascular smooth muscle cells
KB Beason, CG Acuff, ME Steinhelper, TS Elton
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1999
Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and disease
BH Lorell
The American Journal of Cardiology 1999
Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk
M Horiuchi, W Hayashida, M Akishita, K Tamura, L Daviet, JY Lehtonen, VJ Dzau
Circulation research 1999
Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development
E Chamoux, L Breault, JG Lehoux, N Gallo-Payet
The Journal of clinical endocrinology and metabolism 1999
Practical Considerations of the Pharmacology of Angiotensin Receptor Blockers
MM McConnaughey, JS McConnaughey, AJ Ingenito
The Journal of Clinical Pharmacology 1999
Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation
DY Li, YC Zhang, MI Philips, T Sawamura, JL Mehta
Circulation research 1999
Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy
Z Cao, R Dean, L Wu, D Casley, ME Cooper
Hypertension 1999
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
M Horiuchi, M Akishita, VJ Dzau
Hypertension 1999
Opposing actions of angiotensins on angiogenesis
RD Machado, RA Santos, SP Andrade
Life Sciences 1999
Role of the His273 Located in the Sixth Transmembrane Domain of the Angiotensin II Receptor Subtype AT2 in Ligand–Receptor Interaction
CA Turner, S Cooper, L Pulakat
Biochemical and Biophysical Research Communications 1999
Adding losartan to lisinopril therapy in patients with hypertension: Assessment by 24-hour ambulatory blood pressure monitoring
R Fogari, A Zoppi, L Corradi, L Poletti, E Piazza, A Mugellini, EB Pilun, P Preti
Current Therapeutic Research 1999
Role of Arg182 in the Second Extracellular Loop of Angiotensin II Receptor AT2 in Ligand Binding
J Kurfis, D Knowle, L Pulakat
Biochemical and Biophysical Research Communications 1999
Actions of endothelin-1 on cultured rat renomedullary interstitial cells are modulated by nitric oxide
C Maric, G P Aldred, A M Antoine, E Eitle, R G Dean, D A Williams, P J Harris, D Alcorn
Clinical and experimental pharmacology & physiology 1999
Role of AT 1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice
TJ Bivalacqua, A Dalal, HC Champion, PJ Kadowitz
American journal of physiology. Endocrinology and metabolism 1999
Renal cellular response to ureteral obstruction: role of maturation and angiotensin II
RL Chevalier, BA Thornhill, JT Wolstenholme
American journal of physiology. Renal physiology 1999
Effect of AT 2 receptor blockade on the pathogenesis of renal fibrosis
JJ Morrissey, S Klahr
American journal of physiology. Renal physiology 1999
Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT 1 receptor and PKC activation
D Li, B Yang, MI Philips, JL Mehta
American journal of physiology. Heart and circulatory physiology 1999
Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
GE Sander, JJ McKinnie, SS Greenberg, TD Giles
Progress in Cardiovascular Diseases 1999
Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT 1 receptors
NW Morrell, PD Upton, S Kotecha, A Huntley, MH Yacoub, JM Polak, J Wharton
American journal of physiology. Lung cellular and molecular physiology 1999
Activation of the AT 2 Receptor of Angiotensin II Induces Neurite Outgrowth and Cell Migration in Microexplant Cultures of the Cerebellum
F Côté, TH Do, L Laflamme, JM Gallo, N Gallo-Payet
The Journal of biological chemistry 1999
Activation of the de novo Biosynthesis of Sphingolipids Mediates Angiotensin II Type 2 Receptor-induced Apoptosis
JY Lehtonen, M Horiuchi, L Daviet, M Akishita, VJ Dzau
The Journal of biological chemistry 1999
Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors
S Gunasegaram, RS Haworth, DJ Hearse, M Avkiran
Circulation research 1999
Differential Regulation of Renal Angiotensin Subtype AT 1A and AT 2 Receptor Protein in Rats With Angiotensin-Dependent Hypertension
ZQ Wang, LJ Millatt, NT Heiderstadt, HM Siragy, RA Johns, RM Carey
Hypertension 1999
Mechanical Stretch and Angiotensin II Differentially Upregulate the Renin-Angiotensin System in Cardiac Myocytes In Vitro
R Malhotra, J Sadoshima, FC Brosius, S Izumo
Circulation research 1999
Role of AT 2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR
RM Touyz, D Endemann, G He, JS Li, EL Schiffrin
Hypertension 1999
AT 2 Receptor Stimulation Enhances Antihypertensive Effect of AT 1 Receptor Antagonist in Hypertensive Rats
MN Barber, DB Sampey, RE Widdop
Hypertension 1999
Angiotensin II Type 2 Receptor Blockade Amplifies the Early Signals of Cardiac Growth Response to Angiotensin II in Hypertrophied Hearts
J Bartunek, EO Weinberg, M Tajima, S Rohrbach, BH Lorell
Circulation 1999
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
EA Tallant, DI Diz, CM Ferrario
Hypertension 1999
AT 2 Receptor and Vascular Smooth Muscle Cell Differentiation in Vascular Development
H Yamada, M Akishita, M Ito, K Tamura, L Daviet, JY Lehtonen, VJ Dzau, M Horiuchi
Hypertension 1999
Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo
L Pastore, A Tessitore, S Martinotti, E Toniato, E Alesse, MC Bravi, C Ferri, G Desideri, A Gulino, A Santucci
Circulation 1999
Intracellular Sodium Modulates the Expression of Angiotensin II Subtype 2 Receptor in PC12W Cells
M Tamura, Y Wanaka, EJ Landon, T Inagami
Hypertension 1999
Angiotensin II Stimulates Collagen Synthesis in Human Vascular Smooth Muscle Cells: Involvement of the AT 1 Receptor, Transforming Growth Factor-β, and Tyrosine Phosphorylation
CM Ford, S Li, JG Pickering
Arteriosclerosis, thrombosis, and vascular biology 1999
Effects of Candesartan and Cilazapril on Rats With Myocardial Infarction Assessed by Echocardiography
M Yoshiyama, K Takeuchi, T Omura, S Kim, H Yamagishi, I Toda, M Teragaki, K Akioka, H Iwao, J Yoshikawa
Hypertension 1999
Role of Angiotensin Receptor Blockers in Heart Failure: Not Yet RESOLVD
BH Greenberg
Circulation 1999
In Vivo Study of AT 1 and AT 2 Angiotensin Receptors in Apoptosis in Rat Blood Vessels
QN Diep, JS Li, EL Schiffrin
Hypertension 1999
Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis
JY Lehtonen, L Daviet, C Nahmias, M Horiuchi, VJ Dzau
Molecular Endocrinology 1999
Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain**This work was supported by a grant from the NIH (NS-19441) and a postdoctoral fellowship (to U.V.S.) from the American Heart Association, Florida Affiliate
UV Shenoy, EM Richards, XC Huang, C Sumners
Endocrinology 1999
AT1-Rezeptorblockade
P Dominiak, G Heusch
1999
Molecular Cardiology in Clinical Practice
M Sanders, JB Kostis
1999
Hormones and the Heart in Health and Disease
L Share
1999
Angiotensin II AT1-Rezeptorantagonisten
P Dominiak, T Unger
1999
Signals from the AT2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Protein Kinase) to Induce Morphological Neuronal Differentiation in NG108–15 Cells
L Gendron, L Laflamme, N Rivard, C Asselin, MD Payet, N Gallo-Payet
Molecular Endocrinology 1999
Comparative Safety and Tolerability of Angiotensin II Receptor Antagonists:
L Mazzolai, M Burnier
Drug Safety 1999
Characterization of AT2 receptor expression in NIH 3T3 fibroblasts
F M Heemskerk, S Zorad, N Xu, S J Gutkind, J M Saavedra
Cellular and Molecular Neurobiology 1999

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
94 readers on Mendeley
See more details